Clinical trial

Lithium Carbonate in Treating Patients With Acute Intestinal…

NCT00408681 · Fred Hutchinson Cancer Center, Other · Completed

Key facts

NCT number NCT00408681
Title Lithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem Cell Transplant
Official title A Pilot Study to Evaluate the Potential Efficacy of Lithium Carbonate for Stimulation of Intestinal Recovery In Patients With Acute Graft-versus-host Disease (GVHD)
Acronym GVHD
Lead sponsor Fred Hutchinson Cancer Center, Other
Collaborators National Cancer Institute (NCI) NIH
Status Completed
Study type Interventional
Conditions Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13, q22), Adult Acute Myeloid Leukemia With t(15, 17)(q22, q12), Adult Acute Myeloid Leukemia With t(16 and 111 more
Intervention type Drug, Other
Interventions lithium carbonate, laboratory biomarker analysis
Enrollment 20
Start date Jun 1, 2006
Primary completion Nov 1, 2010
Completion May 1, 2015
First posted Dec 7, 2006
Last update posted Mar 7, 2017
Countries United States

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies